SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001847903-22-000084
Filing Date
2022-11-10
Accepted
2022-11-10 07:09:10
Documents
60
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnta-20220930.htm   iXBRL 10-Q 1819791
2 EX-31.1 a20220930exhibit311.htm EX-31.1 10046
3 EX-31.2 a20220930exhibit312.htm EX-31.2 12221
4 EX-32.1 a20220930exhibit321.htm EX-32.1 5351
5 EX-32.2 a20220930exhibit322.htm EX-32.2 5165
  Complete submission text file 0001847903-22-000084.txt   5879831

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20220930.xsd EX-101.SCH 33385
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnta-20220930_cal.xml EX-101.CAL 45600
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20220930_def.xml EX-101.DEF 202654
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20220930_lab.xml EX-101.LAB 469858
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20220930_pre.xml EX-101.PRE 321200
54 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20220930_htm.xml XML 705713
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40445 | Film No.: 221374901
SIC: 2834 Pharmaceutical Preparations